Received May 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | N/A | MC7HK | IM / LA |
TDAP administered into left deltoid on 01/08/2025. On 02/03/2025, patient notified clinic of left arm pain. Patient denied skin color changes; no fever; no itching; no redness. Patient returned to clinic on 03/03/2025 for an unrelated issues. Patient did not express and reference to the previous left arm pain. On 03/11/2025, patient sent an electronic message to the provider indicating still having left arm pain / soreness. Patient was seen for follow up on 03/20/2025. At that appointment, patient denied numbness, tingling, weakness. Physician ordered a treatment plan of NSAIDs/ice and an ultrasound of the left arm to assist with determining cause/source of pain. Received a phone call on 04/29/2025 to discuss left arm pain. Per patient, she is still experiencing left arm pain although it has markedly improved. Ultrasound was not completed.
Sleeping Difficulties; Fatigue
GERD; Anxiety; Iron Deficiency
Famotidine; Ferrous Sulfate and Trazodone
Tobradex; Azithromycin; Paxlovid
Treatment plan provided on 03/20/2025: Tylenol/NSAID's for 2 weeks with regular application of ice packs. Left arm ultrasound ordered.